Cargando…

Metabolic parameters on baseline (18)F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma

PURPOSE: We evaluated baseline (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters for predicting prognosis in patients with head and neck squamous cell carcinoma (HNSCC) who were receiving immune checkpoint inhibitors (ICIs). In addition, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Hye Ryeong, Cho, Junhun, Park, Sehhoon, Lee, Se-Hoon, Ahn, Myung-Ju, Choi, Joon Young, Lee, Kyung-Han, Jung, Hyun Ae, Moon, Seung Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548588/ https://www.ncbi.nlm.nih.gov/pubmed/36226146 http://dx.doi.org/10.3389/fmed.2022.896494

Ejemplares similares

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Kim, Hana, et al.
Publicado: (2023)

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma
por: CASTALDI, P., et al.
Publicado: (2013)

Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma
por: Hur, Joon Young, et al.
Publicado: (2022)

(18)F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma
por: Surov, Alexey, et al.
Publicado: (2019)

Detection of distant metastases and distant second primary cancers in head and neck squamous cell carcinoma: comparison of [(18)F]FDG PET/MRI and [(18)F]FDG PET/CT
por: Katirtzidou, Eirini, et al.
Publicado: (2022)

The prognostic value of radiomic features from pre- and post-treatment (18)F-FDG PET imaging in patients with nasopharyngeal carcinoma
por: Kim, Soo Jeong, et al.
Publicado: (2023)

Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using (18)F-FDG PET
por: Yoon, Joon-Kee, et al.
Publicado: (2019)

(18)F-FDG PET versus (18)F-FDG PET/CT for Adrenal Gland Lesion Characterization: a Comparison of Diagnostic Efficacy in Lung Cancer Patients
por: Sung, Yon Mi, et al.
Publicado: (2008)

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)

Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping
por: Lim, Chae Hong, et al.
Publicado: (2021)

Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by (18)F-FDG PET/CT
por: Niccoli Asabella, Artor, et al.
Publicado: (2021)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Predictive value of quantitative (18)F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
por: Kim, Hongsik, et al.
Publicado: (2023)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

The impact of baseline (18)F-FDG PET-CT on the management and outcome of patients with gastric cancer
por: Foley, Kieran G, et al.
Publicado: (2022)

Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations
por: Jun, Soojin, et al.
Publicado: (2023)

The Clinical Meaning of Benign Colon Uptake in (18)F-FDG PET: Comparison with Colonoscopic Findings
por: Roh, Sun Hee, et al.
Publicado: (2012)

Impact of combined (18)F-FDG PET/CT in head and neck tumours
por: Syed, R, et al.
Publicado: (2005)

Contribution of (18)F-FDG PET/CT to Staging of Head and Neck Malignancies
por: Ceylan, Yeşim, et al.
Publicado: (2018)

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
por: Dequanter, D, et al.
Publicado: (2015)

Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer
por: Park, Jisang, et al.
Publicado: (2020)

Incidental findings on 18-FDG PET–CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET–CT in patients with head and neck cancer
por: Casselden, Elizabeth, et al.
Publicado: (2018)

The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma
por: Prestwich, Robin J. D., et al.
Publicado: (2012)

Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous (18)F-FDG-PET and MRI
por: Chen, Jenny, et al.
Publicado: (2020)

Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma
por: Bianchini, Chiara, et al.
Publicado: (2023)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

Effects of cigarette smoking on metabolic activity of lung cancer on baseline (18)F-FDG PET/CT
por: Jiang, Maoqing, et al.
Publicado: (2022)

Primary Benign Intraosseous Meningioma on (18)F-FDG PET/CT Mimicking Malignancy
por: Kim, Ho Seong, et al.
Publicado: (2014)

Interim 4′-[methyl-(11)C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [(18)F]FDG PET
por: Mitamura, Katsuya, et al.
Publicado: (2021)

Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations
por: Kim, Gahyun, et al.
Publicado: (2020)

Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma
por: Meyer, Hans-Jonas, et al.
Publicado: (2018)

Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis
por: Jin, Aihua, et al.
Publicado: (2022)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

Use of baseline 18F-FDG PET scan to identify initial sub-volumes with local failure after concomitant radio-chemotherapy in head and neck cancer
por: Legot, Floriane, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jegb48fc7jbrch6jiiiami91m7